Breaking News
December 9, 2018 - Eliminating microglia can reverse some aspects of stress sensitization, study shows
December 9, 2018 - New genetic insight could help treat rare debilitating heart and lung condition
December 9, 2018 - MiRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 9, 2018 - Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism
December 9, 2018 - CWRU researcher secures $14.6 million funding for genetic study into Alzheimer’s disease
December 9, 2018 - High intensity statin treatment and adherence could save more lives
December 9, 2018 - Surgery patients use only 1/4 of prescribed opioids, and prescription size matters
December 9, 2018 - AXT offers Phi Optics upgrade to QPI systems for inverted light microscopes
December 9, 2018 - New booklet could help improve conditions of young pupils with albinism
December 9, 2018 - Few Physicians Work in Practices That Use Telemedicine
December 9, 2018 - Older Adults and Oral Health
December 9, 2018 - Health utility values improve after septorhinoplasty
December 9, 2018 - New EU-funded project provides insight into how the brain develops
December 9, 2018 - Expanded use of tele-emergency services can help strengthen rural hospitals
December 9, 2018 - Infections in the Young May Be Tied to Risk for Mental Illness: Study
December 9, 2018 - Profile: Native Hawaiians and Pacific Islanders
December 9, 2018 - Snoring poses greater cardiac risk to women
December 9, 2018 - Researcher takes further steps in understanding how and why cute aggression occurs
December 9, 2018 - Researchers create new light-activated tools for controlling neurons
December 9, 2018 - Spinal cord injury disrupts the body’s internal clock, study shows
December 9, 2018 - Babies recognize nested structures similar to our grammar
December 9, 2018 - UT Austin researcher receives $2.5 million CZI grant for neurodegenerative disease research
December 9, 2018 - Sleep problems found to be prevalent and increasing among college students
December 9, 2018 - Study reveals why some children are susceptible to the effects of maltreatment
December 9, 2018 - Study investigates influence of different opioids on driving performance
December 9, 2018 - Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia
December 9, 2018 - Eliminating microglia prevents heightened immune sensitivity after stress
December 9, 2018 - Boys with social difficulties are at greatest risk of early substance use
December 9, 2018 - ‘Wrong’ connective tissue cells linked to worse prognosis in breast cancer patients
December 8, 2018 - Chronic, refractory schizophrenia patients benefit from targeted cognitive training
December 8, 2018 - Advertising in kids’ apps more prevalent than parents may realize
December 8, 2018 - New way to trace the transmission histories of rare genetic diseases
December 8, 2018 - ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
December 8, 2018 - Results of pediatric genomic epilepsy tests often reclassified
December 8, 2018 - New way of controlling HIV latency to completely eradicate the virus
December 8, 2018 - Phasefocus to showcase the Livecyte 2 at ASCB
December 8, 2018 - KHN’s ‘What the Health?’ Is health spending the next big political issue?
December 8, 2018 - Mussels take in microplastic pollution fibers and flush most of them out again
December 8, 2018 - AHA: How to Stop Smoking … for Good
December 8, 2018 - Scientists overturn odds to make Parkinson’s discovery
December 8, 2018 - Health benefits of producing marula vinegar
December 8, 2018 - Failure of critical cellular energy sensor responsible for CKD progression, study finds
December 8, 2018 - Ethnicity can be reliable indicator of gut microbiota diversity
December 8, 2018 - Safe Sleep for Baby | NIH News in Health
December 8, 2018 - Study looks at ways technology can support nutritional needs of Parkinson’s patients
December 8, 2018 - Infant milk allergy is being overdiagnosed say experts
December 8, 2018 - Graphene may one day be used to test for ALS
December 8, 2018 - Houston Methodist launches real-time website to track flu cases
December 8, 2018 - RedHill Announces Positive Top-Line Results from Confirmatory Phase 3 Study with Talicia for H. pylori Infection
December 8, 2018 - A way to measure obesity and health beyond BMI
December 8, 2018 - New diagnostic tools may help identify breast cancer patients who could benefit from targeted therapies
December 8, 2018 - Duke-NUS researchers highlight possible role of bioaerosol sampling in pandemic surveillance
December 8, 2018 - Study quantifies links between alcohol, drug use and violent deaths
December 8, 2018 - Mothers’ stress levels at conception linked to child’s response to life challenges at age 11
December 8, 2018 - MIT researchers develop antimicrobial peptides from South American wasp’s venom
December 8, 2018 - Obesity prevention among low-income, diverse preschool-aged children and parents
December 8, 2018 - Mount Sinai researcher awarded $2.5 million to advance understanding of neurodegenerative diseases
December 8, 2018 - CZI announces funding for open-source software efforts to improve image analysis in biomedicine
December 8, 2018 - New book encompasses the vast history of reproduction
December 8, 2018 - Low-income women in Texas are not receiving contraception after childbirth, study shows
December 8, 2018 - Study expands knowledge about sexuality and gender gaps in political attitudes
December 8, 2018 - Drug reduces hot flash frequency, improves quality of life in breast cancer survivors
December 8, 2018 - Imaging, Biopsy Often Still Needed After Mastectomy
December 8, 2018 - Physical Activity Guidelines for Americans: 2nd edition
December 8, 2018 - Machine learning can improve chemical toxicity prediction
December 8, 2018 - Researchers explore why and how Mediterranean diet may mitigate cardiovascular risk
December 8, 2018 - Multigene test is a helpful decision making tool in breast cancer treatment, study shows
December 8, 2018 - New EZ-2 centrifugal evaporator to safely remove solvents from cytotoxic drug preparations
December 8, 2018 - UMGCCC uses Gammapod radiotherapy to treat breast cancer patients
December 8, 2018 - Men with inflammatory bowel disease have higher prostate cancer risk
December 8, 2018 - Newly developed molecules may provide more reliable relief for people with autoimmune diseases
December 8, 2018 - Exercise program during adjuvant breast cancer treatment may provide cardiovascular benefits
December 8, 2018 - Acutely injured deceased-donor kidneys are suitable for transplant, study suggests
December 8, 2018 - Researchers find two connective tissue cells to be linked to worse prognosis of breast cancer
December 8, 2018 - VCU researchers test vaccine against opioid abuse
December 8, 2018 - An App, Your Fingernail — and Anemia Screening Is Done
December 8, 2018 - New study offers hope for patients suffering from a rare form of blindness
December 8, 2018 - Study finds increasing risk of infections and antibiotic prescriptions after hip fracture surgery
December 8, 2018 - Biosense Webster treats first patient in U.S. IDE study of HELIOSTAR RF Balloon Ablation Catheter
December 8, 2018 - Researchers develop new molecular tool to decode sugar-protein attachments
Deep brain stimulation not effective for treating early Alzheimer’s

Deep brain stimulation not effective for treating early Alzheimer’s

image_pdfDownload PDFimage_print
Credit: CC0 Public Domain

A new study from Johns Hopkins shows that individuals with early onset Alzheimer’s disease—those under the age of 65—don’t benefit from deep brain stimulation, a treatment already proven to be effective for easing motor symptoms of people with Parkinson’s disease.

“Our results suggest that as we look at deep brain stimulation as a treatment for Alzheimer’s disease, we should probably focus on those over 65, which is the bulk of people with Alzheimer’s,” says Jeannie-Marie Leoutsakos, associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine. “Over the years, there’s been little in the pipeline that is promising for Alzheimer’s, so there are now plans in the works for a larger trial only including people over 65.”

Alzheimer’s disease is a progressive brain disorder that affects memory and thinking skills and eventually limits the ability to carry out simple tasks. According to the National Institute on Aging, experts suggest that more than 5.5 million Americans may have Alzheimer’s, which is currently considered the sixth leading cause of death in the U.S.

The researchers say halting or reversing declining cognition is a tall order and unlikely, but even slowing or delaying decline would have significant public health impacts in terms of care costs and patient and family quality of life.

The study included people with early onset and late-onset Alzheimer’s, because researchers didn’t think initially that one group would be more likely than the other to be responsive. A total of 42 people with mild Alzheimer’s had deep brain stimulation devices implanted in the brain in a spot between the hippocampus, which is responsible for learning and memory, and the hypothalamus, which regulates body temperature, hunger, and thirst. Twelve participants were under 65 with early onset Alzheimer’s and 20 participants were over 65. Half the devices were turned on at the beginning of the first year; the other half of the devices were turned on after a year. Each device delivered continuous stimulation at 130 hertz between 3 and 3.5 volts—a stimulation similar to that successfully used on people with Parkinson’s disease.

To track clinical dementia rating and progression of disease, the researchers used two questionnaires that looked at word memory, cognitive tasks, judgment, and personal care. They also used PET scans to track changes in the participants’ brain structure.

The researchers didn’t see any benefit such as slowing of cognitive decline for those participants under age 65. They still declined on the tests at the same rate as those people who hadn’t had their devices turned on and forgot words in the test as often. There is a possibility of benefit among participants over 65 in that they didn’t seem to be declining as fast as those without the device turned on, but researchers won’t know for sure unless they complete a larger study.

As to why there wasn’t a clear benefit in those with early onset Alzheimer’s, the researchers suggest that it’s possible that the participants may have been too far into the disease progression to make a difference. It’s possible that the early onset condition is a different disease progression, and the PET scans in their study did show that younger patients had more deficits in metabolism than the older patients.

Eight participants reported serious adverse events such as falls, fainting, seizures, infection, and mental agitation after having the brain implant. According to the researchers, the safety profile is similar to or better than those of medications that are being developed to treat Alzheimer’s disease.

The findings are published in the July issue of the Journal of Alzheimer’s Disease.


Explore further:
New appropriate use criteria for lumbar puncture in Alzheimer’s diagnosis

More information:
Jeannie-Marie S. Leoutsakos et al. Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation, Journal of Alzheimer’s Disease (2018). DOI: 10.3233/JAD-180121

Journal reference:
Journal of Alzheimer’s Disease

Provided by:
Johns Hopkins University

Tagged with:

About author

Related Articles